Alpha DNA Investment Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,818	Closed	-$433K	–	159
2024 Q4	$433K	Buy	+7,818	New	+$433K	0.16%	146
2024 Q3	–	Sell	-15,174	Closed	-$412K	–	250
2024 Q2	$412K	Buy	15,174 +1,261	+9%	+$34.3K	0.16%	152
2024 Q1	$506K	Buy	+13,913	New	+$506K	0.19%	146